0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Discordances of Digoxin

JAMA. 1973;224(2):243-244. doi:10.1001/jama.1973.03220150051016.
Text Size: A A A
Published online

As contrasted with the sluggish digitoxin, digoxin is regarded as a glycoside that is uniformly absorbed and eliminated with considerable rapidity. Recent reports, however, disclose a frequent lack of equivalence in digoxin plasma levels, inconsistencies in its elimination rates, and discrepancies between the latter and its chronotropic effects.

Discussing bioavailability problems of digoxin, Wagner and associates (p 199) point out that in addition to individual tablet-to-tablet variations in potency due to poor mixing in manufacture, there are substantial potency differences between brands of digoxin. A two-way crossover study in eight subjects, demonstrated a 41% difference between peak plasma levels attained with tablets belonging to two well-known brands. This difference correlated well with the in vitro rate of dissolution of the tablets and thus could be easily predicted.

Less predictable than the lack of equivalence in bioavailability of digoxin are the inconsistencies in its elimination rates. In a study of five

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();